Literature DB >> 25543524

Activation of oxidative stress and inflammatory factors could account for histopathological progression of aflatoxin-B1 induced hepatocarcinogenesis in rat.

Krishna Beer Singh1, Brajesh Kumar Maurya, Surendra Kumar Trigun.   

Abstract

Aflatoxin-B1 (AFB1) intoxication is known to develop hepatocellular carcinoma (HCC). However, pathogenesis and diagnosis of AFB1-induced HCC remain undefined. This article describes histopathological progression versus kinetics of the placental glutathione S-transferase (GST-pi) expression and profiles of the antioxidant enzymes, pro-inflammatory cytokines, and proliferative cell nuclear antigen (PCNA) in the liver from the rats administered with two doses of 1 mg AFB1/kg b.w. Histopathologically, hepatocytes necrosis could be observed after 4 weeks of the AFB1 treatment, which subsequently developed into the well-defined foci of altered hepatocytes (FAH) at 10 weeks post-treatment stage. This was consistent with an increasing trend of GST-pi immunostaining especially in the liver foci as a function of FAH progression and thus, suggesting that GST-pi over expression may serve as a marker for AFB1-induced hepatocarcinogenesis. The liver from AFB1-treated rats showed significantly enhanced level of reactive oxygen species coinciding with the declined immunostaining for superoxide dismutase-1, a committed enzyme of the antioxidant pathway, in the FAH regions and also with declined activity of the other antioxidant enzymes. Concordantly, the liver from the AFB1-treated rats showed over expression of pro-inflammatory cytokines; TNF-α & IL-1α and a cell proliferative marker PCNA. These findings present histological characterization of AFB1-induced HCC development and provide evidence for activation of oxidative stress-pro-inflammatory pathway during hepatocarcinogenesis induced by AFB1 toxicity.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25543524     DOI: 10.1007/s11010-014-2306-x

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  52 in total

Review 1.  Cyclins and cell cycle checkpoints.

Authors:  D G Johnson; C L Walker
Journal:  Annu Rev Pharmacol Toxicol       Date:  1999       Impact factor: 13.820

2.  Constitutive aberrant endogenous interleukin-1 facilitates inflammation and growth in human melanoma.

Authors:  Yong Qin; Suhendan Ekmekcioglu; Ping Liu; Lyn M Duncan; Gregory Lizée; Nancy Poindexter; Elizabeth A Grimm
Journal:  Mol Cancer Res       Date:  2011-09-27       Impact factor: 5.852

3.  Acute and chronic hyperammonemia modulate antioxidant enzymes differently in cerebral cortex and cerebellum.

Authors:  Santosh Singh; Raj K Koiri; Surendra Kumar Trigun
Journal:  Neurochem Res       Date:  2007-08-04       Impact factor: 3.996

4.  Cancer chemotherapy and antioxidants.

Authors:  Kenneth A Conklin
Journal:  J Nutr       Date:  2004-11       Impact factor: 4.798

Review 5.  Metabolic activation of aflatoxin B1: patterns of DNA adduct formation, removal, and excretion in relation to carcinogenesis.

Authors:  J M Essigmann; R G Croy; R A Bennett; G N Wogan
Journal:  Drug Metab Rev       Date:  1982       Impact factor: 4.518

6.  Activation of neuronal nitric oxide synthase in cerebellum of chronic hepatic encephalopathy rats is associated with up-regulation of NADPH-producing pathway.

Authors:  Santosh Singh; Surendra K Trigun
Journal:  Cerebellum       Date:  2010-09       Impact factor: 3.847

7.  Mutations associated with in vivo aflatoxin B1-induced carcinogenesis need not be present in the in vitro transformations by this toxin.

Authors:  L A Stanley; H G Mandel; J Riley; S Sinha; F M Higginson; D J Judah; G E Neal
Journal:  Cancer Lett       Date:  1999-04-01       Impact factor: 8.679

8.  Decreased expression of glutathione peroxidase mRNA in thyroid anaplastic carcinoma.

Authors:  Yukiko Hasegawa; Toru Takano; Akira Miyauchi; Fumio Matsuzuka; Hiroshi Yoshida; Kanji Kuma; Nobuyuki Amino
Journal:  Cancer Lett       Date:  2002-08-08       Impact factor: 8.679

9.  Glutathione Peroxidase 2 Inhibits Cyclooxygenase-2-Mediated Migration and Invasion of HT-29 Adenocarcinoma Cells but Supports Their Growth as Tumors in Nude Mice.

Authors:  Antje Banning; Anna Kipp; Stephanie Schmitmeier; Maria Löwinger; Simone Florian; Susanne Krehl; Sophie Thalmann; René Thierbach; Pablo Steinberg; Regina Brigelius-Flohé
Journal:  Cancer Res       Date:  2008-12-01       Impact factor: 12.701

Review 10.  ROS stress in cancer cells and therapeutic implications.

Authors:  Helene Pelicano; Dennis Carney; Peng Huang
Journal:  Drug Resist Updat       Date:  2004-04       Impact factor: 18.500

View more
  13 in total

1.  Hepatic transcriptomic alterations for N,N-dimethyl-p-toluidine (DMPT) and p-toluidine after 5-day exposure in rats.

Authors:  June K Dunnick; Keith R Shockley; Daniel L Morgan; Amy Brix; Gregory S Travlos; Kevin Gerrish; J Michael Sanders; T V Ton; Arun R Pandiri
Journal:  Arch Toxicol       Date:  2016-09-16       Impact factor: 5.153

2.  Protective and therapeutic effects of sildenafil and tadalafil on aflatoxin B1-induced hepatocellular carcinoma.

Authors:  Saurabh K Chhonker; Divya Rawat; Raj Kumar Koiri
Journal:  Mol Cell Biochem       Date:  2020-11-20       Impact factor: 3.396

3.  Changes in serum cytokine levels, hepatic and intestinal morphology in aflatoxin B1-induced injury: modulatory roles of melatonin and flavonoid-rich fractions from Chromolena odorata.

Authors:  Fadeyemi Joseph Akinrinmade; Akinleye Stephen Akinrinde; Adetayo Amid
Journal:  Mycotoxin Res       Date:  2016-01-22       Impact factor: 3.833

4.  Fisetin Modulates Antioxidant Enzymes and Inflammatory Factors to Inhibit Aflatoxin-B1 Induced Hepatocellular Carcinoma in Rats.

Authors:  Brajesh Kumar Maurya; Surendra Kumar Trigun
Journal:  Oxid Med Cell Longev       Date:  2015-11-22       Impact factor: 6.543

5.  AFB1 hepatocarcinogenesis is via lipid peroxidation that inhibits DNA repair, sensitizes mutation susceptibility and induces aldehyde-DNA adducts at p53 mutational hotspot codon 249.

Authors:  Mao-Wen Weng; Hyun-Wook Lee; Bongkun Choi; Hsiang-Tsui Wang; Yu Hu; Manju Mehta; Dhimant Desai; Shantu Amin; Yi Zheng; Moon-Shong Tang
Journal:  Oncotarget       Date:  2017-03-14

6.  Comparison of the toxic effects of different mycotoxins on porcine and mouse oocyte meiosis.

Authors:  Yujie Lu; Yue Zhang; Jia-Qian Liu; Peng Zou; Lu Jia; Yong-Teng Su; Yu-Rong Sun; Shao-Chen Sun
Journal:  PeerJ       Date:  2018-06-20       Impact factor: 2.984

7.  Lactobacillus bulgaricus or Lactobacillus rhamnosus Suppresses NF-κB Signaling Pathway and Protects against AFB₁-Induced Hepatitis: A Novel Potential Preventive Strategy for Aflatoxicosis?

Authors:  Yuanyuan Chen; Ruirui Li; Qiaocheng Chang; Zhihao Dong; Huanmin Yang; Chuang Xu
Journal:  Toxins (Basel)       Date:  2019-01-04       Impact factor: 4.546

8.  Chitosan nanoparticles and quercetin modulate gene expression and prevent the genotoxicity of aflatoxin B1 in rat liver.

Authors:  Mosaad A Abdel-Wahhab; Abdulhadi Aljawish; Aziza A El-Nekeety; Sekena H Abdel-Aiezm; Heba A M Abdel-Kader; Bertrand H Rihn; Olivier Joubert
Journal:  Toxicol Rep       Date:  2015-05-12

9.  Hemoadsorption Improves Survival of Rats Exposed to an Acutely Lethal Dose of Aflatoxin B1.

Authors:  Karl-Gustav Ruggeberg; Pamela O'Sullivan; Timothy J Kovacs; Kathryn Dawson; Vincent J Capponi; Phillip P Chan; Thomas D Golobish; Maryann C Gruda
Journal:  Sci Rep       Date:  2020-01-21       Impact factor: 4.379

10.  Genome Profiling for Aflatoxin B1 Resistance in Saccharomyces cerevisiae Reveals a Role for the CSM2/SHU Complex in Tolerance of Aflatoxin B1-Associated DNA Damage.

Authors:  Nick St John; Julian Freedland; Henri Baldino; Francis Doyle; Cinzia Cera; Thomas Begley; Michael Fasullo
Journal:  G3 (Bethesda)       Date:  2020-11-05       Impact factor: 3.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.